BackBiodesix Overview
Biodesix Inc

Biodesix Target Price

Where could BDSX trade next? Consensus target price: $37.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.78

Average Target Price

$36.5067.6% upside

2 analysts in the last 4 months

High: $38 | Low: $35

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-25H.C. Wainwright$3874.5% upsideOpen
2026-08-10Canaccord GenuityKyle Mikson$3560.7% upsideOpen
2026-06-24Roth CapitalMax Masucci$3246.9% upsideOpen
2026-06-18Canaccord GenuityKyle Mikson$2724% upsideOpen
2026-06-15H.C. Wainwright$2619.4% upsideOpen
2025-09-19Canaccord Genuity$208.2% downsideOpen
2024-09-16ScotiabankSung Ji Nam$386.2% downsideOpen
2024-07-26Craig-HallumBill Bonello$386.2% downsideOpen

Biodesix (BDSX) FAQ

As of the most recent data, BDSX shows a target price of $37. Scroll down for historical charts and peer comparison views.

If Biodesix moved to the average analyst target of $37, shares would be roughly 67.6% higher than $21.78. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Biodesix's earnings trajectory.

Besides this target price page, Stockcircle has Biodesix's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $37) with ownership activity and broader fundamentals.

Biodesix's target price is $37; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.